MedPath

SYNAGIS

SYNAGIS

Discontinued
DIN Number

02245890

Drug Class

Human

Market Date

Sep 26, 2002

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245890
AIG Number0147401002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
J06BD01 PALIVIZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
AHFS Classification08:18.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

PALIVIZUMABActive
Strength: 100 MG / VIAL
Monograph: PALIVIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.